Insider Trades: 6 ASX 200 directors bought and sold these stocks last week

About this update from Ebos Group Limited

Welcome back to the Insider Trades Series – a weekly summary of on-market ASX 200 director transactions valued at more than $10,000. The trades have all taken place between 29 May and 5 June 2025. Directors have up to 5 business days to notify the ASX of their trades.Top ASX 200 Insider BuysCodeCompanyDateDirectorTypePriceValueNECNine Entertainment 5/06/25Peter TonaghBuy$1.62$199,935ELDElders 29/05/25Damien FrawleyBuy$6.25$125,000EBOEbos Group 30/05/25Mark BloomBuy$34.40$68,800Key takeawaysPeter Tonagh, a seasoned media executive and former Foxtel CFO, joined Nine Entertainment’s board in January and recently acquired his first parcel of shares. The stock is up around 30% year-to-date, boosted by both solid ad revenue trends and M&A. The company’s Q3 update showcased robust TV ad revenue, standout publishing performance driven by customer retention and digital ads, upgraded H2 EBITDA guidance, and sustained growth at Stan, further supported by its 60.1% stake in Domain, currently under offer.Damien Frawley, who joined Elders’ board in August 2024, purchased his first shares last week, despite the stock’s 13% year-to-date decline following a weaker-than-expected first-half FY25 result on 26 May. The key numbers include: Revenue up 5% to $1.41bn vs. $1.56bn ests (9.6% miss)Underlying NPAT up 166% to $38.2m vs. 40.3m ests (5.2% miss)Interim dividend flat year-on-year at 18 cents per shareCEO Mark Allison noted that while dry conditions hampered rural product sales, strong livestock demand drove a 166% NPAT increase, with optimism for improved seasonal conditions and sustained livestock strength in H2.Top ASX 200 Insider SellsCodeCompanyDateDirectorTypePriceValueSIGSigma Healthcare 29/05/25Danielle Di PillaSell$3.18$23,312,794BVSBravura Solutions 2/06/25Matthew QuinnSell$2.50$1,249,500GNCGraincorp 30/05/25Robert SpurwaySell$7.54$797,851Key takeawaysSigma Executive Director Danielle Pilla sold a collective 29.8 million shares (~$94m) between 26-29 May (four separate transactions) at ~$3.15, retaining 75.6 million shares. The stock experienced a 6.6% selloff on 6 May after the company reported 1H25 earnings growth of 36% to $446.1 million. Goldman Sachs attributed the market’s lukewarm response to concerns over slowing Chemist Warehouse growth in Q3, maintaining a Neutral rating with a $2.70 target, noting solid execution but a lofty FY26e P/E of 54x.Graincorp ...

View stock analysis, news, and events for Ebos Group Limited